In a second study [19], higher phospho-MARCKS staining was associated with shorter survival in a series of 195 operated lung cancers and associated with EGFR-TKI-based treatment in a series of 52 treated metastatic patients. The gene discussed is MARCKS; the disease is lung carcinoma.